Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$87.74 - $117.27 $4.46 Million - $5.96 Million
-50,802 Reduced 24.64%
155,411 $15.1 Million
Q4 2022

Feb 14, 2023

SELL
$80.93 - $108.63 $1.35 Million - $1.82 Million
-16,725 Reduced 7.5%
206,213 $21.3 Million
Q3 2022

Nov 14, 2022

SELL
$82.16 - $96.94 $2.27 Million - $2.67 Million
-27,579 Reduced 11.01%
222,938 $18.9 Million
Q2 2022

Aug 15, 2022

SELL
$71.48 - $86.85 $2.96 Million - $3.59 Million
-41,353 Reduced 14.17%
250,517 $20.8 Million
Q1 2022

May 16, 2022

BUY
$74.28 - $92.69 $21.7 Million - $27.1 Million
291,870 New
291,870 $22.5 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Lombard Odier Asset Management (Switzerland) Sa Portfolio

Follow Lombard Odier Asset Management (Switzerland) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.